Our results suggest that NKG2D+CD4+ T cells are a heterogeneous population of cells in CLL, but the increase of these cells in early stage Binet patients argues against an immunosuppressive role for this population. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.